Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article (Mini-Review)

Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors

Author(s): Kang Cheng, Chen-Fu Liu and Guo-Wu Rao*

Volume 28 , Issue 13 , 2021

Published on: 14 May, 2020

Page: [2540 - 2564] Pages: 25

DOI: 10.2174/0929867327666200514082425

Price: $65


Tumor growth inhibition can be achieved by inhibiting angiogenesis, which has been a field of great concern in recent years. Important targets to inhibit angiogenesis include vascular endothelial growth factor receptor (VEGFR) and its homologous tyrosine kinase receptor. Anti-angiogenic therapy based on inhibition of VEGFR-2 is an effective clinical treatment strategy. The research progress of VEGFR-2 inhibitors is reviewed in this paper from the aspects of drug development and chemical synthesis.

Keywords: Tumor, anti-angiogenic agents, tyrosine kinase, VEGFR-2 inhibitor, approved drugs, synthesis.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy